March 2019 Outlook For BioMarin

BioMarin Pharmaceuticals Inc. (BMRN) continues to experience choppy price movements, even as it trades along the path of consolidation.

Part of what has produced some upside movements for BMRN at the beginning of the year was a January announcement of key milestones the company hopes to achieve this year. A summary of these milestones, including the completion of a gene therapy manufacturing plant in California, is provided here.

Original source

Add comment

Please Sign in to be able to leave comments.